iDNA Genomics Public (CYS:IDNA) Net Margin % : 0.00% (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. iDNA Genomics Public's Net Income for the six months ended in . 20 was €0.00 Mil. iDNA Genomics Public's Revenue for the six months ended in . 20 was €0.00 Mil. Therefore, iDNA Genomics Public's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for iDNA Genomics Public's Net Margin % or its related term are showing as below:

CYS:IDNA's Net Margin % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -7.645
* Ranked among companies with meaningful Net Margin % only.

iDNA Genomics Public Net Margin % Historical Data

The historical data trend for iDNA Genomics Public's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public Net Margin % Chart

iDNA Genomics Public Annual Data

Trend

Net Margin %

iDNA Genomics Public Semi-Annual Data

Net Margin %

Competitive Comparison of iDNA Genomics Public's Net Margin %

For the Diagnostics & Research subindustry, iDNA Genomics Public's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iDNA Genomics Public's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iDNA Genomics Public's Net Margin % distribution charts can be found below:

* The bar in red indicates where iDNA Genomics Public's Net Margin % falls into.

Save Embed

;

Save Embed

;

iDNA Genomics Public Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

iDNA Genomics Public's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin	=	Net Income (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

iDNA Genomics Public's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin	=	Net Income (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

iDNA Genomics Public (CYS:IDNA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

iDNA Genomics Public Net Margin % Related Terms

Thank you for viewing the detailed overview of iDNA Genomics Public's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

iDNA Genomics Public Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Evrota 25- 27, Kifissia, GRC, 145 64

Website

https://www.idnagenomics.com

iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.